Related Experiment Videos

[Hematologic causes of vascular diseases of the central nervous system]

A Arboix¹, C Besses, P Acín

¹Unitat de Patologia Vascular Cerebral, La Aliança-Hospital, Barcelona.

Revista De Neurologia

|January 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk.

Leukemia·2020

miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia.

Blood cancer journal·2016

Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method.

Annals of hematology·2016

Brain infarcts in the arterial border zones: Clinical-pathologic correlations.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Leukemia·2014

Movement disorders in ischemic stroke: clinical study of 22 patients.

European journal of neurology·2013

See all related articles